Trending

BNT162b2 vaccine induces moderate SARS-CoV-2 immunity in children 5 to 11

In the present study, researchers identified a cohort of children five to 11 years of age vaccinated for coronavirus disease 2019 (COVID-19) on or after November 23, 2021, with BNT162b2 in Israel. They compared whether vaccination prevented them from …

Read more at www.news-medical.net

Show More

Related Articles

Back to top button